Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: GDC-0032|DRUG: Tamoxifen
Sponsor: The Netherlands Cancer Institute
Collaborators: Genentech, Inc.|EurocanPlatform|Rather